These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 23399651)
61. Studies on the role of sex-hormone-binding globulin (SHBG) in benign prostatic hypertrophy in men. I. Clinical research. Pachman A Int Urol Nephrol; 1984; 16(2):141-7. PubMed ID: 6206017 [TBL] [Abstract][Full Text] [Related]
62. Vitamin D deficiency promotes prostatic hyperplasia in middle-age mice through exacerbating local inflammation. Zhang ZH; Luo B; Xu S; Fu L; Chen YH; Zhang C; Wang H; Xie DD; Xu DX J Steroid Biochem Mol Biol; 2018 Sep; 182():14-20. PubMed ID: 29684478 [TBL] [Abstract][Full Text] [Related]
63. D-hormone and its significance for function of prostate gland (literature review and personal observations). Brechka NM; Bondarenko VO; Shcherbak OV; Korenieva YM Wiad Lek; 2024; 77(1):135-143. PubMed ID: 38431818 [TBL] [Abstract][Full Text] [Related]
64. Optimal high-density lipoprotein cholesterol level for decreasing benign prostatic hyperplasia in men not taking statin medication: A historical cohort study. Yoo S; Oh S; Suh J; Park J; Cho MC; Jeong H; Won S; Son H Prostate; 2020 May; 80(7):570-576. PubMed ID: 32196725 [TBL] [Abstract][Full Text] [Related]
65. Sex-hormone-binding globulin in the plasma of normal men and patients with benign prostatic hypertrophy. Minguell JJ; Merino J; Valladares LE; Troncoso S Arch Androl; 1979; 3(2):167-71. PubMed ID: 92918 [TBL] [Abstract][Full Text] [Related]
66. Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients. Zou C; Gong D; Fang N; Fan Y World J Urol; 2016 Feb; 34(2):281-9. PubMed ID: 26119349 [TBL] [Abstract][Full Text] [Related]
67. Nutritional status and nutritional habits of men with benign prostatic hyperplasia or prostate cancer - preliminary investigation. Goluch-Koniuszy Z; Rygielska M; Nowacka I Acta Sci Pol Technol Aliment; 2013; 12(3):319-30. PubMed ID: 24584961 [TBL] [Abstract][Full Text] [Related]
68. Leptin in relation to prostate cancer and benign prostatic hyperplasia. Lagiou P; Signorello LB; Trichopoulos D; Tzonou A; Trichopoulou A; Mantzoros CS Int J Cancer; 1998 Mar; 76(1):25-8. PubMed ID: 9533757 [TBL] [Abstract][Full Text] [Related]
69. Plasma sex hormone binding globulin in patients with prostatic carcinoma. Grasso M; Buonaguidi A; Mondina R; Borsellino G; Lania C; Banfi G; Rigatti P Cancer; 1990 Jul; 66(2):354-7. PubMed ID: 1695120 [TBL] [Abstract][Full Text] [Related]
70. Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia. Fu S; Xu H; Gu M; Liu C; Wan X; Chen Y; Chen Q; Zhou J; Wang Z Oncotarget; 2017 Oct; 8(51):88537-88551. PubMed ID: 29179455 [TBL] [Abstract][Full Text] [Related]
71. Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study. Wu L; Li BH; Wang YY; Wang CY; Zi H; Weng H; Huang Q; Zhu YJ; Zeng XT Mil Med Res; 2019 Nov; 6(1):34. PubMed ID: 31718713 [TBL] [Abstract][Full Text] [Related]
72. Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. Lin L; Wang W; Xiao K; Guo X; Zhou L J Endocrinol Invest; 2023 Oct; 46(10):2095-2102. PubMed ID: 36913135 [TBL] [Abstract][Full Text] [Related]
73. A medical hypothesis: phosphorus balance and prostate cancer. Kapur S Cancer Invest; 2000; 18(7):664-9. PubMed ID: 11036473 [TBL] [Abstract][Full Text] [Related]
74. Relationship between serum indirect bilirubin and prostate volume in patients with benign prostatic hyperplasia: a cross-sectional study. Ling C; Wu X; Huang W; Pang A; Wu Y; Wang X; Zhang C; Tian Y Ann Transl Med; 2022 Oct; 10(20):1127. PubMed ID: 36388836 [TBL] [Abstract][Full Text] [Related]
75. Body mass index predicts failure of surgical management in benign prostatic hyperplasia. Willder JM; Walker VC; Halbert GL; Dick CP; Orange C; Qayyum T; Horgan PG; Underwood MA; Edwards J Urol Int; 2013; 90(2):150-5. PubMed ID: 23257365 [TBL] [Abstract][Full Text] [Related]
76. Elevated red blood cell distribution width in benign prostatic hyperplasia patients with metabolic syndrome. Dong X; Liao Y; Chen K; Fang Y; Li W; Chen J; You L; Li S Int J Clin Exp Med; 2015; 8(1):1213-9. PubMed ID: 25785115 [TBL] [Abstract][Full Text] [Related]
77. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature. Neuhouser ML; Kristal AR; Penson DF Urology; 2004 Aug; 64(2):201-11. PubMed ID: 15302461 [No Abstract] [Full Text] [Related]
78. Vitamin D and genetic ancestry are associated with apoptosis rates in benign and malignant prostatic epithelium. Stinson J; McCall C; Dobbs RW; Mistry N; Rosenberg A; Nettey OS; Sharma P; Dixon M; Sweis J; Macias V; Sharifi R; Kittles RA; Kajdacsy-Balla A; Murphy AB Prostate; 2023 Mar; 83(4):352-363. PubMed ID: 36479698 [TBL] [Abstract][Full Text] [Related]
79. Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men. Garcia J; Krieger KD; Loitz C; Perez LM; Richards ZA; Helou Y; Kregel S; Celada S; Mesaros CA; Bosland M; Gann PH; Willnow TE; Vander Griend D; Kittles R; Prins GS; Penning T; Nonn L Cancer Res Commun; 2023 Mar; 3(3):371-382. PubMed ID: 36875158 [TBL] [Abstract][Full Text] [Related]